Anusha Kallurkar

ORCID: 0000-0003-0086-0185
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood transfusion and management
  • Anesthesia and Pain Management
  • Pain Management and Opioid Use
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Venous Thromboembolism Diagnosis and Management
  • Pharmacogenetics and Drug Metabolism
  • Cardiac, Anesthesia and Surgical Outcomes
  • Psoriasis: Treatment and Pathogenesis
  • Herbal Medicine Research Studies
  • Pain Mechanisms and Treatments
  • COVID-19 epidemiological studies
  • Shoulder Injury and Treatment
  • Bone Metabolism and Diseases
  • Oral health in cancer treatment
  • Management of metastatic bone disease
  • Pain Management and Treatment
  • Nausea and vomiting management
  • Antioxidant Activity and Oxidative Stress
  • Sleep and Wakefulness Research
  • Disaster Response and Management
  • Bone health and osteoporosis research
  • Viral Infections and Outbreaks Research
  • Erythropoietin and Anemia Treatment
  • Cancer, Stress, Anesthesia, and Immune Response
  • Phytochemistry Medicinal Plant Applications

Louisiana State University Health Sciences Center Shreveport
2019-2025

Medical University of Silesia
2023

Louisiana State University Health Sciences Center New Orleans
2023

Fondazione Roma
2023

Pain Management Institute
2023

Pain is common among patients with head and neck cancer (HNC). However, there are very limited data on chronic pain HNC treated radiation therapy (XRT). In this retrospective study, we focused the characteristics of post-XRT in such patients. Post-XRT patients; however, found discrepancy between frequency treatment pain, suggesting poor documentation medical records. Among who reported to have most them described having severe used descriptors neuropathic pain. Pharynx was commonest site as...

10.1155/2019/9675654 article EN cc-by Pain Research and Management 2019-05-06

Introduction: In recent years, platelets have been in short supply and high demand. Approximately one five cardiac surgery patients require platelets. our safety-net hospital, however, the incidence is over 40%. Renal dysfunction, long cardiopulmonary bypass (CPB) times, absence of tranexamic acid (TXA) are common risk factors for requiring platelet transfusions. Methods: Our hypothesis was fewer would be transfused within two hours after under these three conditions: creatinine low,...

10.20944/preprints202312.1254.v1 preprint EN 2023-12-18

After cardiopulmonary bypass (CPB) approximately 20% of patients require platelets. In our safety-net hospital, the incidence platelet transfusion is over 40%, perhaps attributable to prevalent risk factors renal dysfunction, CPB duration, and absence tranexamic acid (TXA). We designed this retrospective observational study after surgeons decided against offering in presence these factors. The Institutional Review Board (IRB) approved protocol waived informed consent. Our hypothesis was...

10.4081/ahr.2024.5 article EN Advancements in health research. 2024-06-06
Coming Soon ...